Searched for
BSV DEAL
Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...- CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines dealThe Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisiti...
- Mankind Pharma shares in focus as company approves Rs 10,000 crore fundraise planThe company's board of directors on Monday approved raising up to Rs 5,000 crore via non-convertible debentures in 3-4 distinct series with...
- Mankind Pharma to raise Rs 10,000 crore through NCDs, CPs to fund BSV dealThe company will raise up to Rs 5,000 crore through non-convertible debentures (NCDs) maturing in up to 48 months, according to a regulator...
- Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...
- Mankind Pharma eyes ₹9,000 cr via debt to stitch BSV dealThe average blended cost of the debt is likely to be around 8.50% with the firm seeking to borrow money over one- to-five years, said three...
- Mankind Pharma shares drop 2% despite 10% YoY Q1 PAT growth. Buy, sell, or hold?Mankind Pharma's shares fell 2% to Rs 1,985.50, despite the company announcing a 10% YoY rise in net profit to Rs 543 crore for the first q...
- Market not much enthused by Mankind's BSV buyAfter initially cheering the deal, the stock market gave its thumbs-down to Mankind acquiring BSV at the premium valuations of eight times ...
- Mankind to use debt, internal accruals to fund BSV buyoutMankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...
- Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
- Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 croreWarburg Pincus, ChrysCapital, TPG, Blackstone, EQT, Mankind Pharma, and Dr Reddy's Laboratories are competing to acquire BSV Group, a bioph...
- Bharat Serums acquires 26 pc stake in solar power firm AMP Energy C&I One"This solar project resonates our belief in building a greener environment, judiciously using natural resources and renewable sources of en...
- Amazon buys Perpule in all-cash dealAmazon Technologies Inc., a subsidiary of the US-based retailer, acquired Perpule for Rs 107.6 crore in an all-cash deal.
- Advent set to buy controlling stake in Bharat SerumKotak PE and OrbiMed together that hold 23% stake in Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) are exiting through th...
- Advent International emerges sole bidder for Bharat SerumsKotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.
- Carlyle-Zydus and Advent join race to acquire Bharat Serums and Vaccines LtdThey are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers.
- Domestic pharmaceutical players eye Bharat Serums acquisitionThe two funds together hold a 23% stake and the remainder is with the Daftary family.
- NCLT to decide on RCom-Aircel merger on August 14The merger could set the ball rolling for a sale of RCom’s stake in its tower unit to Canada’s Brookfield. Together, the deals could reduce...
- New green norms to make power, fuels, cars costlierThe new environmental norms for coal-fired power plants, for example, are expected to push up electricity cost by 40-50 paise per unit. Mot...
- Government may skip a stage in emission norms to adopt BS-VI standardsThe country's automotive industry would be asked to upgrade and deliver the right technology, the official, who did not wish to be named, a...
Load More
